8-KOther Events

ABBOTT LABORATORIES 8-K Report (Oct 9, 2003)

Filed October 9, 2003For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K report on October 9, 2003, to announce its third-quarter 2003 results of operations. The report primarily refers to a press release, filed as Exhibit 99.1, which details the company's financial performance. Investors should note that Abbott utilized several non-GAAP financial measures in its reporting, including net earnings, diluted earnings per share, gross margin, and sales, each excluding the impact of one-time charges or foreign exchange. Management asserts that these adjustments provide a clearer view of ongoing business performance and are used internally for monitoring. However, the company explicitly advises investors to consider these non-GAAP figures in conjunction with, and not as a replacement for, their GAAP-compliant counterparts.

Key Highlights

  • 1Abbott Laboratories reported its third-quarter 2003 financial results via an 8-K filing on October 9, 2003.
  • 2The primary content of the filing is a press release detailing the company's operational and financial performance for the quarter.
  • 3Abbott utilized non-GAAP financial measures in its earnings announcement, including adjustments for one-time charges and foreign exchange.
  • 4Key non-GAAP metrics highlighted include net earnings, diluted earnings per share, gross margin, and sales.
  • 5Management believes these non-GAAP measures offer a better evaluation of ongoing business performance for investors.
  • 6The company cautioned that non-GAAP measures should be considered alongside, not as a substitute for, GAAP financial measures.

Frequently Asked Questions

The main purpose of this 8-K filing is to report Abbott Laboratories' financial results for the third quarter of 2003, as announced in a press release on October 9, 2003.

Abbott used several non-GAAP financial measures, such as net earnings, diluted earnings per share, gross margin, and sales, that exclude the impact of one-time charges and foreign exchange.

Abbott's management stated that these non-GAAP measures are used to provide investors with useful information about the company's ongoing business performance, as they adjust for unusual or unpredictable factors. Management also uses these measures internally.

Abbott cautioned investors to consider these non-GAAP financial measures in addition to, and not as a substitute for, financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP).